Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Receives $8.24 Consensus PT from Brokerages
Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) have been given an average rating of “Hold” by the nine research firms that are presently covering the firm, Marketbeat reports. Five investment analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12 […]
Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) have been given an average rating of “Hold” by the nine research firms that are presently covering the firm, Marketbeat reports. Five investment analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12 […]
